NYSE · USPH
Healthcare · Medical - Care Facilities
$82.60
Down-$3.13 (-3.65%)
Updated Oct 2, 2026, 2:59 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · USPH
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
USPH closed at $82.60 after 20 trading sessions, up 5.04% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $85.58 | $85.915 | $82.60 | $82.60 | 140.76K |
| Sep 30, 2026 | $86.46 | $87.22 | $85.72 | $85.73 | 137.61K |
| Sep 29, 2026 | $85.66 | $86.39 | $84.625 | $86.15 | 208.18K |
| Sep 28, 2026 | $85.21 | $87.37 | $84.88 | $86.09 | 196.53K |
| Sep 25, 2026 | $83.76 | $85.3099 | $83.76 | $84.84 | 130.58K |
| Sep 24, 2026 | $82.68 | $84.88 | $82.68 | $83.76 | 175.67K |
| Sep 23, 2026 | $83.24 | $83.96 | $81.86 | $82.65 | 133.18K |
| Sep 22, 2026 | $83.27 | $85.26 | $82.4151 | $83.17 | 217.02K |
| Sep 21, 2026 | $82.23 | $83.345 | $81.90 | $82.45 | 169.78K |
| Sep 18, 2026 | $82.73 | $83.265 | $81.35 | $82.47 | 336.79K |
| Sep 17, 2026 | $83.56 | $84.49 | $82.09 | $83.08 | 190.73K |
| Sep 16, 2026 | $81.48 | $84.08 | $79.01 | $83.39 | 173.94K |
| Sep 15, 2026 | $81.11 | $82.71 | $79.20 | $81.75 | 308.38K |
| Sep 14, 2026 | $78.40 | $81.105 | $76.415 | $80.52 | 195.44K |
| Sep 11, 2026 | $79.10 | $79.60 | $78.05 | $78.72 | 184.72K |
| Sep 10, 2026 | $78.20 | $79.195 | $76.965 | $77.71 | 115.78K |
| Sep 9, 2026 | $77.97 | $78.595 | $77.32 | $77.87 | 135.72K |
| Sep 8, 2026 | $78.39 | $79.57 | $77.92 | $78.71 | 164.33K |
| Sep 4, 2026 | $78.41 | $79.74 | $77.77 | $79.35 | 91.8K |
| Sep 3, 2026 | $79.21 | $79.42 | $77.74 | $78.64 | 164.62K |
The latest Smart Investors Daily articles mentioning USPH.
Company
Market Activity
Research & News
USPH research
Company profile and research snapshot.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | JP Morgan | Overweight | — |
| Aug 10, 2026 | Barrington Research | Outperform | — |
| Jun 24, 2026 | Citizens | Market Outperform | — |
| May 13, 2026 | Barrington Research | Outperform | — |
| May 8, 2026 | Citizens | Market Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 21, 2026
HOUSTON, September 21, 2026--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the "Board") approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
Yahoo · Sep 21, 2026
The appointment of Nchacha Etta as Chief Financial Officer has put U.S. Physical Therapy (USPH) back on investor screens, as fresh leadership intersects with renewed debate over the stock’s discounted cash flow valuation. Recent trading has been constructive, with U.S. Physical Therapy showing a 29.87% 90 day share price return and a 5.92% 1 year total shareholder return, even though the 3 year and 5 year total shareholder returns are still in decline. Compare U.S. Physical Therapy’s renewed...
Yahoo · Sep 21, 2026
Earlier this year, U.S. Physical Therapy appointed Nchacha Etta as Chief Financial Officer, marking a change in leadership over the company’s finance function and capital management responsibilities. The move has drawn fresh attention to how effectively the business converts earnings into cash and how its long-term cash flows are being valued. We’ll now examine how the new CFO’s appointment and sharper focus on cash flow quality may influence U.S. Physical Therapy’s investment...
Yahoo · Sep 20, 2026
U.S. Physical Therapy has delivered mixed results for long term holders, with the share price down 21.3% over 5 years despite a recent uptick. This puts fresh focus on whether the current US$82.47 level lines up with the cash the business can generate. With the stock back in positive territory over the past year and new leadership in the finance seat, the question now is how well those cash flows support today’s valuation. The share price decline of 21.3% over 5 years means anyone looking at...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning USPH.
